Showing results (131-140 of 219) with videos related to
Sort By:
Pageof 22
International Journal of Medical Informatics|May 31, 2011
Computerized detection of adverse drug reactions in the medical intensive care unitSandra L Kane-Gill, Shyam Visweswaran, Melissa I Saul, et al.Pharmacoepidemiology and Drug Safety|January 22, 2025
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories AnalysisLanting Yang, Jingchuan Guo, Sandra L Kane-Gill, et al.Therapeutic Advances in Drug Safety|June 19, 2023
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance studyBritney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, et al.Expert Opinion on Drug Safety|March 28, 2014
An evidence based systematic review of remifentanil associated opioid-induced hyperalgesiaRyan M Rivosecchi, Mark J Rice, Pamela L Smithburger, et al.Drug Safety|May 18, 2019
Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-AnalysisMary Grace Fitzmaurice, Adrian Wong, Hannah Akerberg, et al.Journal of Opioid Management|April 27, 2022
Opioid abuse risk among student pharmacistsJena J Patel, Lucio R Volino, Leon E Cosler, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 15, 2007
Implementing an intravenous insulin infusion protocol in the intensive care unitRhonda S Rea, Amy Calabrese Donihi, MaryBeth Bobeck, et al.Pharmacoepidemiology and Drug Safety|August 28, 2020
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 yearsChristian A Andreaggi, Emily A Novak, Mitchell E Mirabile, et al.Journal of Integrative and Complementary Medicine|June 11, 2026
A Retrospective Pharmacovigilance Disproportionality Analysis of Possible Nephrotoxicity and Natural Products Using Data from the FDA Adverse Event Reporting SystemCaiden J Lukan, Iman Karimzadeh, Tiffany L Tran, et al.The Annals of Pharmacotherapy|September 5, 2020
A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa ConcentrationsMarissa N Levito, James C Coons, Margaret M Verrico, et al.Pageof 22